In a regulatory filing on Monday, Integra LifeSciences (IART) said that on December 19, 2024, a subsidiary received a warning letter from the U.S. FDA ... improving its quality management system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback